DrugMapper


Display Options: Drug type Therapeutic Area Route of administration Mechanism of Action Indication Status		Total: 10647


Antibody Approved Unknown UNKNOWN Blast Crisis; Burkitt Lymphoma; Leukemia, Biphenotypic, Acute; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Hematologic Neoplasms; Leukemia; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Neoplasms; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma CD22 binding agent


Combination Approved Unknown Unknown Unknown Unknown


Small molecule Approved Unknown TOPICAL Wounds and Injuries; Impetigo DNA gyrase inhibitor


Small molecule Approved Unknown ORAL Kidney Diseases; Liver Diseases; Aspergillosis, Allergic Bronchopulmonary; Muscular Dystrophies, Limb-Girdle; Muscular Dystrophies; Muscular Dystrophy, Duchenne Glucocorticoid receptor agonist


Small molecule Approved Unknown Unknown Kidney Diseases; Liver Diseases; Renal Insufficiency, Chronic; Stress Disorders, Post-Traumatic; Hepatitis C; Hepatitis C, Chronic Hepatitis C virus serine protease, NS3/NS4A inhibitor


Unknown Approved Unknown Unknown Unknown Unknown


Enzyme Approved Unknown Unknown Neuronal Ceroid-Lipofuscinoses Polypeptides proteolytic enzyme


Small molecule Approved Unknown OPHTHALMIC Glaucoma; Glaucoma, Open-Angle; Ocular Hypertension Prostanoid FP receptor agonist


Small molecule Approved Unknown Unknown Liver Diseases; Biliary Tract Neoplasms; Malignant Carcinoid Syndrome; Neuroendocrine Tumors; Pancreatic Neoplasms; Carcinoid Heart Disease Tryptophan 5-hydroxylase inhibitor


Enzyme Approved Unknown INJECTION Unknown Unknown


Small molecule Approved Unknown ORAL Chagas Disease; Leishmaniasis; Trypanosomiasis Unknown


Small molecule Approved Unknown Unknown Glaucoma, Open-Angle; Corneal Edema; Fuchs' Endothelial Dystrophy; Glaucoma Unknown


Small molecule Approved Unknown Unknown Cachexia; Dwarfism, Pituitary Ghrelin receptor agonist


Antibody Approved Unknown INJECTION; INTRAVENOUS Carcinoma, Pancreatic Ductal; Central Nervous System Neoplasms; Chordoma; Fallopian Tube Neoplasms; Glioma; Head and Neck Neoplasms; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Melanoma; Meningioma; Mesothelioma; Peritoneal Neoplasms; Primary Myelofibrosis; Prostatic Neoplasms; Uveal Melanoma; Adenocarcinoma; Carcinoma, Adenoid Cystic; Carcinoma, Hepatocellular; Carcinoma, Neuroendocrine; Colorectal Neoplasms; Endometrial Neoplasms; Esophageal Neoplasms; Gestational Trophoblastic Disease; Glioblastoma; Hemangiosarcoma; Hodgkin Disease; Kidney Neoplasms; Leiomyosarcoma; Lymphoma; Multiple Myeloma; Nasopharyngeal Neoplasms; Osteosarcoma; Pancreatic Neoplasms; Paraganglioma; Prostatic Neoplasms, Castration-Resistant; Rectal Neoplasms; Skin Neoplasms; Small Cell Lung Carcinoma; Thymoma; Triple Negative Breast Neoplasms; Urinary Bladder Neoplasms; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Carcinoma, Squamous Cell; Colonic Neoplasms; Lymphoma, Large B-Cell, Diffuse; Ovarian Neoplasms; Stomach Neoplasms; Urogenital Neoplasms; Carcinoma, Merkel Cell; Carcinoma, Transitional Cell; Neoplasms; Neuroendocrine Tumors Programmed cell death 1 ligand 1 other

Antibody

Approved

Unknown

INJECTION; INTRAVENOUS

Carcinoma, Pancreatic Ductal; Central Nervous System Neoplasms; Chordoma; Fallopian Tube Neoplasms; Glioma; Head and Neck Neoplasms; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Melanoma; Meningioma; Mesothelioma; Peritoneal Neoplasms; Primary Myelofibrosis; Prostatic Neoplasms; Uveal Melanoma; Adenocarcinoma; Carcinoma, Adenoid Cystic; Carcinoma, Hepatocellular; Carcinoma, Neuroendocrine; Colorectal Neoplasms; Endometrial Neoplasms; Esophageal Neoplasms; Gestational Trophoblastic Disease; Glioblastoma; Hemangiosarcoma; Hodgkin Disease; Kidney Neoplasms; Leiomyosarcoma; Lymphoma; Multiple Myeloma; Nasopharyngeal Neoplasms; Osteosarcoma; Pancreatic Neoplasms; Paraganglioma; Prostatic Neoplasms, Castration-Resistant; Rectal Neoplasms; Skin Neoplasms; Small Cell Lung Carcinoma; Thymoma; Triple Negative Breast Neoplasms; Urinary Bladder Neoplasms; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Carcinoma, Squamous Cell; Colonic Neoplasms; Lymphoma, Large B-Cell, Diffuse; Ovarian Neoplasms; Stomach Neoplasms; Urogenital Neoplasms; Carcinoma, Merkel Cell; Carcinoma, Transitional Cell; Neoplasms; Neuroendocrine Tumors

Programmed cell death 1 ligand 1 other


Small molecule Approved Unknown Unknown Kidney Diseases; Liver Diseases; Renal Insufficiency, Chronic; Stress Disorders, Post-Traumatic; Hepatitis C; Hepatitis C, Chronic Nonstructural protein 5A inhibitor


Protein Approved Unknown SUBCUTANEOUS Fractures, Bone; Osteoporosis; Osteoporosis, Postmenopausal Parathyroid hormone receptor agonist


Small molecule Approved Unknown Unknown Hepatitis C; Hepatitis C, Chronic Hepatitis C virus serine protease, NS3/NS4A inhibitor


Protein Approved Unknown ORAL; SUBCUTANEOUS Bone Diseases, Metabolic; Alcoholism; Asthma; Depressive Disorder, Major; Diabetic Nephropathies; Ischemic Stroke; Liver Diseases; Parkinson Disease; Polycystic Ovary Syndrome; Substance-Related Disorders; Tobacco Use Disorder; Alzheimer Disease; Cardiovascular Diseases; Coronary Disease; Diabetes Mellitus, Type 1; Klinefelter Syndrome; Non-alcoholic Fatty Liver Disease; Nutrition Disorders; Pseudotumor Cerebri; Diabetes Mellitus; Diabetes Mellitus, Type 2; Obesity; Overweight Glucagon-like peptide 1 receptor agonist

Protein

Approved

Unknown

ORAL; SUBCUTANEOUS

Bone Diseases, Metabolic; Alcoholism; Asthma; Depressive Disorder, Major; Diabetic Nephropathies; Ischemic Stroke; Liver Diseases; Parkinson Disease; Polycystic Ovary Syndrome; Substance-Related Disorders; Tobacco Use Disorder; Alzheimer Disease; Cardiovascular Diseases; Coronary Disease; Diabetes Mellitus, Type 1; Klinefelter Syndrome; Non-alcoholic Fatty Liver Disease; Nutrition Disorders; Pseudotumor Cerebri; Diabetes Mellitus; Diabetes Mellitus, Type 2; Obesity; Overweight

Glucagon-like peptide 1 receptor agonist


Small molecule Approved Unknown ORAL Communicable Diseases; Glioblastoma; Leukemia; Leukemia, Prolymphocytic; Lymphoma; Multiple Myeloma; Arthritis, Rheumatoid; Bronchiolitis Obliterans Syndrome; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Food Hypersensitivity; Hematologic Neoplasms; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Ovarian Neoplasms; Pancreatic Neoplasms; Waldenstrom Macroglobulinemia; Lymphoma, Large B-Cell, Diffuse; Severe Acute Respiratory Syndrome; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Mantle-Cell; Neoplasms Tyrosine-protein kinase BTK inhibitor

Small molecule

Approved

Unknown

ORAL

Communicable Diseases; Glioblastoma; Leukemia; Leukemia, Prolymphocytic; Lymphoma; Multiple Myeloma; Arthritis, Rheumatoid; Bronchiolitis Obliterans Syndrome; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Food Hypersensitivity; Hematologic Neoplasms; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Ovarian Neoplasms; Pancreatic Neoplasms; Waldenstrom Macroglobulinemia; Lymphoma, Large B-Cell, Diffuse; Severe Acute Respiratory Syndrome; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Mantle-Cell; Neoplasms

Tyrosine-protein kinase BTK inhibitor


Small molecule Approved Unknown Unknown Hypersensitivity; Substance Withdrawal Syndrome; Cocaine-Related Disorders; Opioid-Related Disorders Unknown


Small molecule Approved Unknown Unknown Hematologic Neoplasms; Liver Diseases; Multiple Myeloma; Neoplasms; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Leukemia Unknown


Small molecule Approved Unknown ORAL Liver Diseases; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Rectal Neoplasms; Myelodysplastic Syndromes; Leukemia; Leukemia, Mast-Cell; Leukemia, Myeloid, Acute; Mastocytosis; Mastocytosis, Systemic; Neoplasms Platelet-derived growth factor receptor inhibitor


Small molecule Approved Unknown INTRAVENOUS Kidney Diseases; Liver Diseases; Brain Injuries; Cerebral Hemorrhage; Stroke; Ischemic Stroke; Amyotrophic Lateral Sclerosis Unknown


Small molecule Approved Unknown Unknown Fallopian Tube Neoplasms; Leukemia, Lymphocytic, Chronic, B-Cell; Lung Neoplasms; Paraganglioma; Peritoneal Neoplasms; Rectal Neoplasms; Sarcoma, Ewing; Stomach Neoplasms; Urogenital Neoplasms; Carcinoma, Pancreatic Ductal; Carcinoma, Squamous Cell; Colorectal Neoplasms; Endometrial Neoplasms; Glioblastoma; Head and Neck Neoplasms; Lymphoma; Melanoma; Mesothelioma; Pancreatic Neoplasms; Penile Neoplasms; Prostatic Neoplasms; Urinary Bladder Neoplasms; Uterine Cervical Neoplasms; Biliary Tract Neoplasms; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Hereditary Breast and Ovarian Cancer Syndrome; Ovarian Neoplasms; Prostatic Neoplasms, Castration-Resistant; Small Cell Lung Carcinoma; Neoplasms Poly [ADP-ribose] polymerase-1 inhibitor

Small molecule

Approved

Unknown

Fallopian Tube Neoplasms; Leukemia, Lymphocytic, Chronic, B-Cell; Lung Neoplasms; Paraganglioma; Peritoneal Neoplasms; Rectal Neoplasms; Sarcoma, Ewing; Stomach Neoplasms; Urogenital Neoplasms; Carcinoma, Pancreatic Ductal; Carcinoma, Squamous Cell; Colorectal Neoplasms; Endometrial Neoplasms; Glioblastoma; Head and Neck Neoplasms; Lymphoma; Melanoma; Mesothelioma; Pancreatic Neoplasms; Penile Neoplasms; Prostatic Neoplasms; Urinary Bladder Neoplasms; Uterine Cervical Neoplasms; Biliary Tract Neoplasms; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Hereditary Breast and Ovarian Cancer Syndrome; Ovarian Neoplasms; Prostatic Neoplasms, Castration-Resistant; Small Cell Lung Carcinoma; Neoplasms

Poly [ADP-ribose] polymerase-1 inhibitor


Small molecule Approved Unknown Unknown Carcinoma; Carcinoma, Hepatocellular; Colorectal Neoplasms; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Ovarian Neoplasms; Stomach Neoplasms; Carcinoma, Non-Small-Cell Lung; Glioblastoma; Hemangiosarcoma; Prostatic Neoplasms; Biliary Tract Neoplasms; Breast Neoplasms; Neoplasms Epidermal growth factor receptor erbB1 inhibitor


Oligonucleotide Approved Unknown Unknown Amyloid Neuropathies, Familial; Amyloidosis Unknown


Unknown Approved Unknown Unknown Unknown Unknown


Small molecule Approved Unknown Unknown Cystic Fibrosis Cystic fibrosis transmembrane conductance regulator positive modulator


Small molecule Approved Unknown Unknown Carcinoma, Non-Small-Cell Lung; Kidney Diseases; Leukemia; Liver Diseases; Myelodysplastic Syndromes; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Neoplasms Tyrosine-protein kinase receptor FLT3 inhibitor

Antibody

Approved

Unknown

Carcinoma, Renal Cell; Diffuse Intrinsic Pontine Glioma; Fallopian Tube Neoplasms; Head and Neck Neoplasms; Hepatitis B, Chronic; HIV Infections; Lymphoma, Follicular; Mycosis Fungoides; Neoplasm Metastasis; Ovarian Neoplasms; Stomach Neoplasms; Urinary Bladder Neoplasms; Urogenital Neoplasms; Breast Neoplasms; Carcinoma, Merkel Cell; Colorectal Neoplasms; Glioblastoma; Hemangiosarcoma; Hodgkin Disease; Liposarcoma; Lymphoma; Multiple Myeloma; Oropharyngeal Neoplasms; Pancreatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Skin Neoplasms; Carcinoma, Non-Small-Cell Lung; Melanoma; Uterine Cervical Neoplasms; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Lung Neoplasms; Neoplasms

Programmed cell death protein 1 inhibitor


Antibody Approved Unknown Unknown Osteoarthritis, Knee; Pain; Migraine Disorders Calcitonin gene-related peptide inhibitor


Small molecule Approved Unknown Unknown Smallpox; Virus Diseases Envelope phospholipase OPG057 inhibitor


Combination Approved Unknown Unknown Unknown Unknown

Small molecule

Approved

Unknown

ORAL

Liver Diseases; Lymphoma, Large B-Cell, Diffuse; Melanoma; Mycosis Fungoides; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Sezary Syndrome; Arthritis, Rheumatoid; Asthma; Carcinoma, Squamous Cell; Hematologic Neoplasms; Leukemia; Leukemia, Lymphoid; Lymphoma; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell, Peripheral; Severe Acute Respiratory Syndrome; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Follicular; Neoplasms

Unknown


Small molecule Approved Unknown INHALATION Kidney Diseases; Liver Diseases; Lung Diseases, Obstructive; Pulmonary Disease, Chronic Obstructive Muscarinic acetylcholine receptor M3 antagonist